Phase 3 NSCLC (Advanced Non-small Cell Lung Cancer) Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more

Revolution Medicines, Inc.590 enrolled143 locationsNCT06881784

Recruiting

Phase 3

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

NSCLC (Advanced Non-small Cell Lung Cancer)EGFR

Allist Pharmaceuticals, Inc.300 enrolled2 locationsNCT06956001